Step 1: Recall the pharmacology of halothane. Halothane is a halogenated inhalational anaesthetic that is a potent direct myocardial depressant.
Step 2: Cardiovascular effects. It produces a dose-dependent reduction in myocardial contractility and cardiac output, leading to a fall in mean arterial pressure (commonly on the order of a 20-30 mm Hg drop) that is roughly proportional to the depth of anaesthesia. Unlike many agents it does not cause a compensatory tachycardia - heart rate tends to stay the same or fall (it blunts the baroreceptor reflex).
Step 3: Arrhythmogenic potential. Halothane also sensitises the myocardium to catecholamines, predisposing to ventricular arrhythmias, especially with exogenous adrenaline or hypercarbia.
Step 4: Why the others are wrong. Halothane decreases (not increases) cardiac output, does not raise SVR/cause hypertension, and certainly is not haemodynamically neutral - its hypotensive, cardiodepressant effect is one of its defining features.
Key fact: Halothane causes a dose-dependent fall in cardiac output and blood pressure (a 20-30 mm Hg drop) through direct myocardial depression.